- Home
- AGIO vs AI Comparison
AGIO vs AI Comparison
Compare AGIO & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- AI
- Stock Information
- Founded
- AGIO 2007
- AI 2009
- Country
- AGIO United States
- AI United States
- Employees
- AGIO N/A
- AI 891
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- AI Computer Software: Prepackaged Software
- Sector
- AGIO Health Care
- AI Technology
- Exchange
- AGIO Nasdaq
- AI Nasdaq
- Market Cap
- AGIO 3.0B
- AI 4.8B
- IPO Year
- AGIO 2013
- AI 2020
- Fundamental
- Price
- AGIO $55.68
- AI $37.43
- Analyst Decision
- AGIO Buy
- AI Hold
- Analyst Count
- AGIO 7
- AI 9
- Target Price
- AGIO $52.33
- AI $27.25
- AVG Volume (30 Days)
- AGIO 740.7K
- AI 5.5M
- Earning Date
- AGIO 10-31-2024
- AI 12-09-2024
- Dividend Yield
- AGIO N/A
- AI N/A
- EPS Growth
- AGIO N/A
- AI N/A
- EPS
- AGIO 11.80
- AI N/A
- Revenue
- AGIO $32,871,000.00
- AI $325,433,000.00
- Revenue This Year
- AGIO $33.38
- AI $26.87
- Revenue Next Year
- AGIO $163.06
- AI $20.98
- P/E Ratio
- AGIO $4.72
- AI N/A
- Revenue Growth
- AGIO 36.79
- AI 18.84
- 52 Week Low
- AGIO $20.96
- AI $18.85
- 52 Week High
- AGIO $62.58
- AI $38.30
- Technical
- Relative Strength Index (RSI)
- AGIO 62.44
- AI 80.06
- Support Level
- AGIO $52.09
- AI $25.39
- Resistance Level
- AGIO $62.58
- AI $33.50
- Average True Range (ATR)
- AGIO 2.91
- AI 1.98
- MACD
- AGIO -0.11
- AI 1.01
- Stochastic Oscillator
- AGIO 64.30
- AI 99.75
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.